More challenges for AstraZeneca in India as it recalls steriles
This article was originally published in Scrip
Executive Summary
AstraZeneca, on 29 February, announced that it was recalling a range of sterile products manufactured at its Bangalore plant in India, after they failed to meet its own standards. Production of the steriles at the facility has since been stopped.